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This project aimed to aid legislators by presenting quantitative evidence on what policies 
existing literature supports as working in dealing with the problem of heroin use in order 
to shift policies to a more effective approach.  Chi Square analysis of 100 quantitative 
studies revealed that there is a relationship between the type of approach and outcome of 
the study, indicating that maintenance-focused approaches are more likely to work than 
the other approaches examined.  The study concluded that, while the literature finds 
consensus on the idea that “maintenance works”, the details of implementation cause 
disagreement between fields; overall, maintenance works for those who want it to work 
and policy makers should focus on implementing broad legislation where the details of 
policy can be worked out based on each community’s unique situation, the demand for 
services, and in seeking to use resources in the most effective and efficient manner. 
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Few topics incite such an emotionally strong reaction as does heroin. In today’s 
society, it has become synonymous with abuse, destruction, and even death, and no one is 
immune from its effects on individuals and society as a whole.  Not only have national 
and international directives sought to place heightened importance on prevention of the 
destruction in peoples’ lives caused by heroin, but policymakers have faced increasing 
pressure from their constituencies to solve the problem of heroin. But what exactly is the 
problem of heroin? It is the quadruped rate of heroin related overdose deaths from 2002 
to 2013 and the 18,893 overdose deaths related to prescription pain relievers and 10,574 
related to heroin in 2014 (Narconon). It is the 586,000 Americans 12 or older who had a 
substance use disorder involving heroin and the 23% of individuals who use heroin and 
develop opioid addiction.  It is the 900% increase in the amount of heroin confiscated in 
Cincinnati between 2010 and 2011, the similar trend in Chicago’s suburbs, and in central 
Michigan, as well as small rural Kentucky and West Virginian towns where as many as 9, 
14, 26, and even 50 individuals have overdosed over the course of a few hours in “mass 
heroin overdoses” (Narconon, Kocher). It is an epidemic worthy of the designation. 
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 This problem has a solution. In fact, the problem has many proposed solutions.  
As these solutions have been tried and evaluated, a large body of literature has focused on 
heroin policy and effectiveness of approaches based on each approach’s unique goals.  
Over time, heroin use and abuse has been approached through many lenses, of crime, 
health, medicine, legal, and economic, among others.  With so many conflicting 
approaches, policymakers have, to date, been limited in their ability to implement 
effective legislation because, although some approaches were seen as more effective than 
others, the many interests of the many groups involved conflicted, hindering the 
realization of the approaches into practice. The current prevalence of heroin use and 
damaging consequences of addiction have acted as a call to action for policy makers, 
however, making them, and society, painfully aware of the lack of implementation of 
effective policy to date. 
This project aimed to aid legislators by presenting quantitative evidence on what 
policies existing literature supports as working in dealing with the problem of heroin use 
in order to shift policies to a more effective approach.  As a secondary objective, it sought 
to address why, in the face of a seemingly present consensus within literature, policy is 
not being implemented.  To gauge the presence of a consensus in existing literature, the 
study used a meta-analysis approach through the review and coding of 100 quantitative 
outcome evaluations of heroin abuse treatment programs or techniques.  Additionally, 
examination of methods used over time in dealing with addiction and the presence of goal 
conflict, groupthink, and misalignment between fields offers a probable explanation for 




Exploring and Explaining the Heroin Epidemic 
 While this analysis aims to divulge the consensus of existing literature regarding 
the most effective approach in dealing with the problem of heroin use and addiction, 
knowing what research says is only half the battle.  Taking that consensus and applying it 
to the situation is often the more difficult step, and it has proven to be so in the heroin 
epidemic as well.  While there seems to be a general literary consensus, even among and 
between fields, very little is being done to implement the policies that have been shown 
to work.  This prompts the questions, “What are the reasons for this consensus?” and 
“Why, despite the consensus, is so little being done to apply it?”  To begin addressing 
these questions, it is helpful to explore what is already known about the heroin epidemic, 
both historically and currently, and to understand the different fields involved, the way 
those fields define and approach aspects of heroin addiction, and the issues plaguing the 
policy-making process that can influence the implementation of policy in response to the 




Heroin in a Historical Context 
  Despite the present state of the heroin epidemic, one could easily believe that it is 
a uniquely American concern that has skyrocketed in social prevalence as of late.  While 
the latter is true, with the Obama administration making clear that addressing the 
epidemic is of the upmost priority at the National Rx Drug Abuse and Heroin Summit in 
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Early 2016 (White House Office of the Press Secretary, 2016), heroin has been an issue 
of universal, rather than exclusively American, concern since the 1800’s and even before. 
 Heroin as a drug has its roots in the long history of opioids, which are derived 
from opium, the poppy plant.  In Mesopotamia in the 3400’s B.C, opium use began.  It 
then expanded from Egypt and Persia to Europe, India, and China, and then to the United 
States in the 1700’s as a therapeutic agent, though users and physicians alike eventually 
noted opium’s addictive qualities.  In 1805, morphine was derived from opium as a pain 
reliever, and because physicians believed that the addictive qualities of opium had been 
tamed with the derivation of morphine, which was lauded as being reliable, long lasting, 
and safe, opium and morphine dependence and addiction increased. This abuse, however, 
was not recreational; rather it stemmed from the physicians’ ignorance to the destructive 
qualities of the drugs, leading to over-use and addiction. In 1874, heroin was synthesized 
for the first time, from morphine by C.R. Wright in England, but it was not produced 
commercially until 1895 when Heinrich Dreser diluted morphine with acetyls producing 
the same heroin (or diacetylmorphine) at Bayer Pharmaceuticals.  Bayer advertised 
heroin as non-addictive and it was also used as a replacement opioid, but this time for 
morphine.  
 Heroin was the penultimate of a series of drugs developed from opium that were 
hoped to, by being purer and stronger, be less addictive than the prior drug.  Additionally, 
in combination with the hypodermic needle, recreational use of the drugs for a high 
became possible during the 19th century.  As each new drug was introduced, touting less 
destructive side effects, the previous was not only replaced, but also censured.  For 
example, after the introduction of morphine and later heroin, Britain passed the Opium 
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Act in 1878 with hopes of reducing opium consumption by restricting the use to 
registered Chinese opium smokers and Indian opium eaters, while San Francisco banned 
smoking opium in the city limits. 
 While it is important to understand the origins of heroin as a drug, this study 
focuses on the perceptions and responses to heroin use and addiction, so understanding 
the societal response alongside the history of the drug is imperative.  Beginning in the 
1800’s in the United Kingdom, recovery and temperance were key solutions to addiction 
and dependence, as seen in the way each new, “safer” opium derivative was used to 
replace the prior, as the prior was condemned and access to it was restricted. This was the 
case, as mentioned, with morphine, and then again in 1898 when heroin was introduced 
as a substitution for morphine.  Additionally, much like the drug use itself, the issue as a 
whole was seen through a medical lens.  This medical lens approached addiction as an 
issue that needed “treatment”, though treatment varied in scope and practice (Berridge 
2012; Mold 2004).  Most often, the treatment was replacing one opioid with another; 
even in the United States in 1900, the St. James Society began sending heroin to 
morphine addicts in order to help them quit.  Though the social issues associated with 
addiction were acknowledged during this time, they were not addressed with as much 
vigor as treating the addiction itself (Mold 2004).  
As time progressed, however, “curing” became the buzz word over “treatment” 
and emphasis was placed on true abstinence (Berridge 2012).  Physicians had begun 
discussing the side effects of using heroin as a step-down cure for morphine and, in a 
series of scholarly articles, many physicians came to the conclusion that the same 
withdrawal symptoms and detrimental effects of addiction were present, regardless of the 
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use of heroin or morphine, and that “treatment” was no longer effective, switching the 
end-goal to a complete curing of the addiction.  In 1906, Alexander Lambert and Charles 
Towns began advocating for their cure for the addiction- a seven-day regimen including a 
five-day purge of the drug from the addicts’ body.  These individuals were greatly 
involved in drug legislation in the United States, in the early 1900’s, which highlights, in 
a way, the general approach taken by the United States in contrast to that taken in the 
United Kingdom.   
In the United States, the approach included prohibitive legislation, a generalized 
approach to the entire problem of opioid use, and initiating an increasingly penal era of 
drug policy; in the United Kingdom, the approach was more centered on the individual 
addicts with treatment (Berridge 2012).  Of course, there were elements of both 
approaches throughout, as seen in Lambert and Towns’ “cure” in the United States and 
legislation passed in the United Kingdom to limit opium use, but generally, the two 
countries approached the issue of heroin and opioid addiction in dissimilar ways.  The 
discrepancy between the two countries may have its roots in the origins of the countries’ 
battles with eradicating opioids, heroin, and the associated addiction.  The United States 
took a tough-on-drugs approach through legislative action and politically charged 
campaigns, bypassing the addicts as a point of action in favor of law enforcement and 
legislation.    Because of this, the United States got caught up in the language and details 
of combatting addiction and the heroin epidemic, making reaching a policy consensus 
impossible since the many groups involved had different goals, definitions, and thought 
processes. England’s roots of approaching addiction medically and with treatment for the 
individuals affected by addiction, however, allowed them to focus on the addiction itself 
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and find a solution through supportive, rather than restrictive, legislation that got at the 
root of the problem- the addicts. Overall, the culprit seems to have been federalism and 
separation of powers in the United States versus a unitary parliamentary government in 
England.  Because this was happening in the Progressive Era, when federal authority was 
generally expanding, the issue was dealt with federally rather than by the states, meaning 
the governments’ systems were influential on the way the countries progressed in dealing 
with the heroin epidemic. 
With the focus on prohibitive legislation in the United States, the early 1900’s 
saw much legislative action, including the U.S. Congress’s Pure Food and Drug Act, 
which required that medicines have contents labeling and reduced the availability and 
consumption of opiates, and the county’s first federal drug prohibition in 1909, which 
outlawed the import of opium.  This ban was in preparation for the Shanghai Conference, 
which aimed to address the ongoing problem of opioid trade between India, China, and 
western Europe.  At the conference, the U.S. encouraged suppressing the sale of opium to 
China and, headed by Dr. Hamilton Wright and Episcopal Bishop Henry Brent, the 
American delegation attempted to convince the rest of the international delegates of the 
detrimental effects of opium.  In 1914, the Harrison Narcotics Act was passed, which 
required physicians register and pay a tax to prescribe narcotics, and in 1919, the League 
of Nations met, where American legislators pressed for international restrictions on drugs 
and trafficking.  In 1922, the Narcotics Import and Export Act was passed, which 
restricted the importation of opium with the exception of medical use, and 1923 saw the 
U.S. Treasury Department’s Narcotic’s Division ban all legal narcotics sales, forcing the 
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sale and use of heroin to addicts and the streets.  Finally, in 1924, the Heroin Act made 
the manufacture and possession of heroin illegal. 
With the onslaught of legislation through the 1910’s and 20’s, addiction began to 
be redefined as a social disease, especially in America, away from one experienced on the 
individual level. In this transition, the two spheres- social and individual- were distinct in 
dealing with the problem; the health of addicts was of medical concern while the social 
problems were addressed by law enforcement and the penal system (Mold 2004).  This 
separation was a root of much contradiction and confusion in the early days of heroin 
policy.  In the United Kingdom, 1926 saw the introduction of the Rolleston Report, 
which advocated the idea that medicine needed to be involved in treating the addiction, 
shifting the focus of addiction back from crime to disease and sparking the “British 
System” of maintenance and liberal pragmatism (Berridge 2012; Mold 2004; Seddon, 
Ralphs, and Williams 2008). Within this era, the Atlantic separated the two main 
approaches toward heroin policy, with America maintaining supply- and demand-
reduction through penal measures and Europe, and especially Britain, emphasizing harm-
reduction and treatment of the addiction.  The 1920’s, then, set the tone for the next 40 
years of drug and addiction policy and, as the decades progressed, there was an emphasis 
on locating the disease within society.  To do this, surveillance and government 
intervention were increased, and, combined with approaching the issue with a public 
health motivation, merging of the medical and social aspects of drug addiction began 
(Berridge 2012, Mold 2004). 
The 1960’s and 70’s saw drastic changes to drug policy in America.  U.S. 
involvement in Vietnam was blamed for the surge in smuggled heroin, and the number of 
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addicts reached over 750,000.  While Britain and other European countries had been 
treating addiction as a medical issue with heroin maintenance treatment for years and 
would continue to do so even into the present (Uchtenhagen 2011), harm reduction and 
maintenance treatment were being introduced for the first time in America as pioneered 
by Vincint Dole and Marie Nyswander in 1963 (Berridge 2012; Latowsky 2006; 
Uchtenhagen 2011).  This maintenance approach did not use heroin, however, because it 
was still stigmatized as an illicit drug; rather, methadone was the substitution drug of 
choice because it was viewed as a medical intervention, in contrast to the fear of enabling 
addicts that would occur with using heroin itself as the maintenance drug (Berridge 
2012).  While morphine was the original substitute for street heroin in the U.S., it was 
abolished as a substitution due to the continuing prohibitive attitude toward drugs that 
plagued American policy during this time; morphine would be viewed similarly to how 
heroin as a substitute would be viewed, as enabling the addict by giving them illicit 
substances (Uchtenhagen 2011).  In 1970, the Controlled Substance Act was passed, 
which categorized drugs, and mandated regulations and penalties for use.  Maintenance 
treatments struggled continuously, and still do, with the stigma attached to drug use and 
the popular view of addiction as criminal behavior.  While America was taking the first 
steps toward harm-reduction during this time, the “British System” was engaged in a 
nuanced shift-in-focus from long-term maintenance with minimum dose prescribing to 
short-term Methadone maintenance with abstinence and recovery as the ultimate goal 
(Berridge 2012). 
The 1980’s became characterized by a universally increased focus on reducing the 
harm from drugs within the context of America’s “War on Drugs”, which many now 
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claim as being overly punitive, expensive, and ineffective (Berridge 2012; Reuter 2013). 
In America, drug use had peaked in the 1970’s and, after tracking specific epidemics, the 
focus was on eradicating the heroin problem (Compton et al. 2005).  Within the 
increasingly punitive approach, which aimed at reducing the supply of and demand for 
heroin, conflict arose as advocates of harm reduction strategies attempted to work toward 
a new public health imperative- preventing the transmission of HIV/AIDS (Berridge 
2012).  There was a renewed hierarchy of objectives in America, with a shift from short-
term maintenance with the goal of abstinence to long-term maintenance and needle-
exchange programs to improve public health (Berridge 2012; Seddon, Ralphs, and 
Williams 2008).  Maintenance programs eventually became a cornerstone for prevention 
of HIV/AIDS and managing dependence to reduce harm for the addicted individuals and 
the community as a whole (Uchtenhagen 2011).  This approach, however, became 
controversial in the United States due to its conflict with the traditional supply- and 
demand-reduction approaches.  Treatment and public health approaches were able to gain 
legitimacy through the “brain disease model”, however, wherein the United States 
National Institute on Drug Abuse introduced addiction as a chronic, relapsing brain 
disorder in need of pharmaceutical interventions (Berridge 2012).  Because of this 
science-based justification, harm-reduction approaches were able to gain support and the 
controversy was somewhat mitigated. 
With this newly introduced view of addiction, the 1990’s began a transition to the 
idea that “Treatment Works” in a variety of objectives, including keeping addicts out of 
prison, which was of growing concern as the criminal justice system began to feel the 
stresses of increased punitiveness over the last few decades.  With this realization, 
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maintenance and methadone were revived alongside public health initiatives.  Within this 
newly user-focused movement, a shift from the community-focused public health 
movement of years before, prescribing was seen as a central strategy for combatting the 
problem (Berridge 2012).  Over the past two decades, maintenance has been advocated as 
important not just for harm-reduction overall, but specifically in preventing the 
transmission of diseases like HIV and AIDS (Latowsky 2006) and more research is being 
done on its effectiveness.   
With the success of methadone as maintenance treatment, Levacetylmethadol 
(LAAM) was approved in 1993 for licensed narcotic treatment programs and the FDA 
granted exclusive authority for dispensing methadone and LAAM for treatment, though 
with many regulatory hurdles (Rawson et al. 1998). In 2002, buprenorphine was 
approved as an additional opioid agonist due to its advantages over methadone, such as 
less stigma, lower overdose rates, and less regulation, and in 2010, naltrexone was 
approved in a new injectable form, which improved adherence rates and blocked the 
reinforcing effects of heroin with no opioid-like effects (Gordon, Kinlock, and Miller 
2012). 
In the more recent past, a ten-year review of the 1998 UN General Assembly 
Special Session’s goal of reducing drug production and consumption concluded that no 
prevention, treatment, or enforcement strategies that have been tried have been effective 
and that, at this point, the goal should be to reduce the damaging consequences of supply- 
and demand- reduction strategies and, instead, focus on other harm-reduction based 
avenues of dealing with the problem (Reuter 2009).  While a solution has not been found 
through the volatile course of policy in the past 200 years, with a constant tug of war 
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between supply- and demand- reduction and harm-reduction approaches, a policy 
consensus would undoubtedly help in addressing heroin as an issue.  As history seems to 
indicate, however, maintenance approaches have survived the test of time and, while they 
have evolved and changed since being used initially, show many benefits in addressing 
heroin addiction as well as the public health issues that arise from it. 
 
 
Understanding the Approaches 
 A large part of understanding not only the history of heroin policy, but also its 
current state and the future of addressing the ever-expanding heroin epidemic, lies in the 
language used by proponents of different policy perspectives and the definitions adhered 
to by professionals in each of many related fields in regard to the potential approaches.  
After delineating the two main spheres of policy, more nuanced positions within the 
approaches will be explained, as will be the different focuses of policy related to each 
approach and how the chosen emphasis of different approaches serves to classify studies 
in this meta-analysis. 
 To begin, when dealing with the problem of heroin, there are two main spheres.  
Within these spheres are more fine-tuned approaches.  The first sphere is that of supply 
and demand reduction, which focuses on reducing either the amount of the drug available 
(supply reduction) or the demand for that drug (demand reduction), typically through 
regulation or prohibition (Greenfield and Paoli 2012).  Typically, this approach is 
punitive in nature, and has been historically advocated for by the criminal justice system 
and those adhering to a crime-control model of thinking.  Under this thought process, 
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controlling crime and criminals in the main goal of policy, with proponents accentuating 
the big picture of reducing crime to protect and better society through enforcing laws and 
maintaining social order, as opposed to the protection of individuals.  Supply and demand 
reduction, as a unified crime-control-centered approach, is known to cause unintended 
consequences and have extra costs due to the focus on aggressive use of the criminal 
justice system and quick procedural administration of justice.  Because of this, the 
approach leads to a paradox in that the goal is to improve the societal situation by 
reducing production and consumption, but the adverse consequences often lead to no 
aggregate change in the supply of the drug (Greenfield and Paoli 2012). 
 The second sphere is that of harm reduction, which has a less than clear 
definition.  Rather than a definitive designation, harm reduction is more of a goal, which 
purposes to reduce harm associated with the use of the drug without necessarily reducing 
drug consumption itself.  Reducing use is a principle, but not sole, means of reducing 
harm (Greenfield and Paoli 2012).  The International Harm Reduction Association 
defines harm reduction broadly as, “policies, programs, and practices that aim primarily 
to reduce the adverse health, social and economic consequences of the use of legal and 
illegal psychoactive drugs without necessarily reducing drug consumption”.  
Additionally, harm reduction cuts across the spectrum from safer use to managed use, 
and then further to abstinence.  The approach aims to meet the addicted individual where 
they are without condemning their behaviors, and instead to work with them and the 
community as a whole to minimize the harmful effects of drug use and the individuals’ 
behaviors (Marlatt and Witkiewitz 2010).   
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When looking at both supply and demand reduction and harm reduction, there is 
often a juxtaposition of the approaches and of those who adhere to each school of 
thought.  Opponents of harm reduction tend to fear that reducing the harmfulness of the 
drug use will increase use, while opponents of use reduction fear reducing use of the 
drugs will increase the harmfulness of the drug use.  It has come to be understood, 
however, that both approaches have a role in dealing with any epidemic, including those 
of drugs like heroin, but each approach has strengths and weaknesses that must be 
considered in implementation, and they must ultimately be used at different times and 
when most appropriate and beneficial, rather than being advocated as being universally 
beneficial (Caulkins, Tragler, and Wallner 2009). 
Within harm reduction strategies, there are two main avenues: one dealing with 
the community and the other dealing with the individual.  In dealing with the community 
is the public health approach, where community-based programs such as needle-
exchanges, public education opportunities, and support groups are implemented to 
educate the community as a whole about harms and issues associated with heroin use and 
the effects of the epidemic, as well as to reduce some of the more immediate public 
harms, such as transmission of communicable diseases with needle exchange programs.  
The public health approach centers its strategy of reducing harm within the context of the 
community, placing less focus on the addicts themselves.   
The other avenue within harm reduction is treatment, which focusses on the 
addicted individual and how to treat their addiction, as if it is a sickness or disease 
(Gelkopf, Levitt, and Bleich 2002), but also with the intention of educating the addicts 
and encouraging responsible use and personal accountability for their addiction 
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(Koutroiulis 2000).  Sometimes, abstinence is the ultimate goal of treatment, but within 
the treatment aspect of harm reduction is the notion that harm can be reduced without 
necessitating that users stop their drug use, which is, while less ambitious, more 
achievable than an ultimate objective of abstinence (Koutroulis 2000). 
My meta-analysis focuses on treatment approaches, distinguishing between 
maintenance and all other treatment approaches, which often encompass abstinence as the 
primary treatment goal whether the method be rehabilitation, detoxification, behavioral 
and cognitive therapies, or forced withdrawal.  Abstinence, as a treatment approach, 
focuses on the addiction with the end goal of ending the addiction through whatever 
means necessary.  On the other hand, maintenance approaches focus on survival and 
allowing the addicted individuals to proceed as more-or-less functioning members of 
society while reducing the harm associated with their use. Under maintenance, abstinence 
or beating the addiction is a secondary goal of treatment, with emphasis placed on the 
health and survival of the addict. 
To understand the goal of maintenance treatments, it is important to understand 
the alternative- withdrawing.  The process for withdrawing from opioids like heroin is so 
torturous that most individuals cannot physically or emotionally bear it, leading to 
relapse.  Individuals feel as though they are dying and, in a sense, they are, because their 
bodies are unable to function without the presence of the drug in their systems.  Addicts 
are dependent on the drug to function and live, so maintenance treatments, which focus 
on survival, allow individuals to maintain their normal level of functioning in society, 
maintaining their quality of life by managing the addiction with drugs that are safer, more 
controlled, administered clinically, and ultimately can be reduced slowly, over time, 
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under the supervision of professionals, and with less withdrawal symptoms.  In this way, 
maintenance treatments offer the benefit of being a way to achieve long-term abstinence, 
but in a way that is not as emotionally, mentally, or physically damaging, and in a way 
that is more manageable and sustainable as to prevent relapse. 
Within maintenance treatments, there are a multitude of specific approaches, 
utilizing different drugs, dosages, time frames, maintenance schedules, administration 
procedures, environments, requirements of the addicts, and costs.  Exploring each of 
these is beyond the scope of this meta-analysis, mainly because maintenance as a broad 
approach works, and the lack of implementation lies the smaller details of specific 
maintenance treatments, on which policy makers and professionals cannot agree. This 
study, as will be explained in more detail later, does not discriminate between the details 
of maintenance treatments. Instead, it simply classifies the studies as either maintenance 
or not maintenance, based on the treatment approach used. Because of this, the study is 
unable to discern between maintenance approaches nor is it able to evaluate the efficacy 
among them. 
 
Policy and Problems 
 With an understanding of the history of heroin and the language associated with 
strategies of combatting the epidemic, it is apparent that there is still much to be done in 
regards to research on the topic.  While heroin itself is not a new problem, the prevalence 
of the problem is, and historically appropriate approaches are no longer so.  The 
consensus of the literature, as will be confirmed by this meta-analysis, is that under the 
umbrella of harm-reduction strategies, treatment options, and more specifically 
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maintenance treatments, are effective in dealing with the heroin problem based on a 
variety of goals for “effectiveness”.  With that consensus, the main concern lies in why 
these policies and strategies are not being implemented. This leads to the question of 
why, in the face of mounting evidence in favor of maintenance treatment approaches to 
heroin, there is a lack of policy consensus and implementation.  This project takes steps 
to answer this question, first by quantitatively analyzing literature to identify a potential 





This project was a meta-analysis of quantitative studies regarding approaches to 
heroin addiction and abuse.  The goal of this analysis was to aid legislators by presenting 
quantitative evidence on what policies work best in dealing with the problem of heroin 
use so that this knowledge can be used to shift policies to a more effective approach.  The 
procedures for conducting this analysis can be described as follows: 1, determine the 
inclusion criteria for studies; 2, identify and select studies; 3, review and coding of 
studies; 4, Chi-Square analysis of coded results. 
1. Inclusion Criteria 
Without access to software programs used in most meta-analyses that screen 
abstracts from large databases, and without the man-power that can be used to 
supplement and review the work of abstract screening software, I was severely limited in 
my study selection.  Because of these limitations, my data collection was done 
 19 
completely by hand.  At the beginning of the project, I determined a simple set of 
inclusion criteria that I would use to determine the eligibility of studies.  This criteria, 
however, was modified and refined as the project continued.   
Eligible studies were determined to be quantitative outcome evaluations of heroin 
abuse treatment programs or specific techniques.  The original set of inclusion criteria 
mandated random-controlled trials and either pre-test-post-test or treatment-comparison 
designs, however this criterion was determined to be too stringent considering the severe 
ethical limitations in dealing with special populations, as many of the studies did.  
Additionally, my inclusion criteria did not limit the location, age group, or timeframe of 
studies because I wanted to combat the effects of groupthink and goal conflict by 
integrating quantitative studies from a very diverse dataset to truly arrive at a consensus 
of the broad literature available on the subject. 
2. Selection of Studies 
The starting point for selecting items was my knowledge of existing literature and 
conversations with experts and colleagues in various fields.  Additionally, I utilized 
online databases, specifically Web of Science, and inspected the bibliographies and 
reference lists of existing meta-analyses.  My final list of analyzed sources was compiled 
mostly from the reference lists of existing meta-analyses exploring similar topics as mine 
aimed to explore.  The reasoning behind this was two fold. First, without an inclusion 
criteria filter to screen for quality in the studies, I operated under the assumption that 
studies that were included in other meta-analyses (of which, all utilized both 
abstract/database screening software and large teams of reviewers and coders) were 
deemed by those researchers to be of quality and, therefore, were of a standard of quality 
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that could be included in my analysis. Second, without advanced database screening 
software, utilizing smaller collections of pertinent studies was beneficial in the issue of 
practicality. 
While my inclusion criteria are incredibly simple and would seem to open the 
floodgates of allowing studies to be included, I also utilized soft-screening practices 
throughout my search to determine if a study was eligible.  Upon determining an existing 
meta-analysis was examining a topic tantamount to mine, I screened its list of analyzed 
sources to ensure that the studies included were quantitative outcome studies and fit the 
scope of my research question.  If they did not, they were excluded.  Additionally, the 
studies that seemingly fit my inclusion criteria were screened for moral and ethical 
legitimacy, as well as for general quality and a lack of questionable methods.  While 
these soft screening measures were rudimentary, they allowed for a second line of 
defense in preventing poor studies from being included, similar to when more complex 
meta-analyses use teams of reviewers and coders to determine eligibility of studies 
identified by the abstract-screening software. 
3. Review and Coding 
When it came to reviewing and coding the studies, it was imperative that I 
maintain the initially determined scope of my project.  In reviewing the studies, it became 
increasingly apparent that there are a multitude of approaches, utilizing different drugs, 
dosages, time frames, maintenance schedules, administration procedures, environments, 
requirements of the addicts, and costs, as well as other factors.  Exploring each of these 
details and the efficacy of each variable is beyond the scope of my project, mainly 
because the review of existing literature found that maintenance as a whole works, and 
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the lack of implementation lies in these smaller details of treatment, on which policy 
makers do not agree.  It is important to note that, because of this, my meta-analysis does 
not discriminate between variation on these details, and merely classifies the study as 
maintenance or not maintenance. Therefore, it will not be able to discern between each 
variation of maintenance treatment in terms of efficacy. 
Upon compilation of the studies to be analyzed, the resulting dataset included 100 
studies. Of these 100 studies, four were supply or demand reduction and 96 were harm 
reduction.  Of those 96 harm reduction studies, 12 were classified as not maintenance and 
84 were classified as maintenance.  Additionally, of the 100 studies total, 80 were 
deemed to have worked and 20 were deemed to have not worked.  
Once the initial list was compiled, coding began.  To code the studies, I identified 
general definitions or criteria for the categories into which I sorted the studies.  First, 
each study was given a unique identification number from 1 to 100.  From there, each 
study was classified as Harm-Reduction or Not Harm-Reduction (and therefore Supply- 
or Demand- Reduction), receiving either a 1 or 0 respectively.  A very basic definition 
was used to classify the overreaching approach.  If the study’s primary method of 
treatment, intervention, or technique under study predominantly aimed to reduce the 
harm associated with heroin use (regardless of if the harm reduction was geared toward 
the user/addict or the community/society at large), it was classified as harm reduction. 
Similarly, if the study’s primary method of treatment, intervention, or technique under 
study predominantly aimed to reduce the supply or demand of heroin in an environment 
(community, society, state, prison setting, etc.), it was classified as supply- or demand- 
reduction. 
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The next step of coding was to determine the harm-reduction approach as being 
maintenance or not maintenance, being coded as 1 or 0 respectively.  Of note, is that 
those studies that were classified as supply- or demand- reduction were automatically 
coded as a 0 at this stage because a supply- or demand- reduction strategy is, of its own 
nature, not maintenance.  To classify a study as maintenance, it had to meet the following 
criteria: 1, participants in the study were given a drug in order to substitute for or control 
their heroin use; 2, the drug was given at a specific dosage at specific intervals, and these 
dosages and intervals were permitted to vary over the course of treatment; 3, the drug was 
given under the assumption it would reduce the harm associated with non-managed drug 
use and/or to maintain the participants’ quality of life; and 4, the treatment procedure was 
not required to aim at reducing the amount of substitution drug over time to reach 
abstinence, but it could be an included treatment goal. 
The final step of coding was to determine if the study worked or did not work.  
While “worked” and “did not work” are very vague terms, dealing with such a variety of 
study types and a variety of outcomes meant that setting a more stringent term or 
classification would be impractical and burdensome.  Because each field, approach, and 
study could have different goals, discerning one specific goal by which to judge such a 
variety of studies did not seem realistic, especially because I was dealing with a very 
comprehensive and broad collection of studies.  To classify a study as having worked or 
not worked, I examined three aspects of the study.  First, I examined the conclusion and 
results sections of each study to determine the goal of the study as well as the outcome. I 
specifically looked for statements indicating the success of the treatment, approach, or 
technique under study based on its specific goals.  Second, I examined comparative 
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statements of success.  In some studies, a variety of maintenance approaches or a variety 
of supply- or demand- reduction strategies were compared.  In those cases, I examined 
the comparative success of each strategy or variation and looked for statements indicating 
their relative success to each other and other strategies.  Third, I examined each study 
under a lens of discretion, where I used logic, reason, and rationale to determine whether 
not only the authors determined the approach to work or not work, but also whether I 
determined the approach to have worked in the context of the study as well.  Of note, is 
that some studies were excluded in this step of coding if the study was ambiguous in 
results or if it was equivocal whether the approach “worked” or “did not work”. 
Once the coding was completed, several trends became apparent. One of which, 
the most apparent and the most worrisome, was that the studies were predominantly 
coded as Harm Reduction-Maintenance-Worked.  While this is troubling, the Chi-Square 
analysis determined that the variance was still enough to draw substantive conclusions 
through statistical significance. Additionally, the cross tabulation table indicates that for 
both supply- and demand- reduction approaches and harm-reduction approaches that 
were not maintenance, more did not work and less did work than if there was no 
relationship between the type of study and its success.  For harm-reduction-maintenance 
approaches, less did not work and more did work than would have if there was no 
relationship.  The p-value also indicates that the difference between the two is large 
enough not to be due simply to random error. 
4. Chi-Square Analysis 
Once the studies were identified and coded, they were analyzed using Chi-Square 
analysis.  This type of analysis was chosen to compare two nominal level variables (the 
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type of approach and whether it worked or did not) and determine if they are reliably 
related to or dependent on each other.  Because I needed to compare across only two 
coding categories rather than three, I introduced a breaking variable, combining the first 
two variables- Supply- or Demand- Reduction versus Harm-Reduction and Maintenance 
versus Not Maintenance.  Therefore, studies that were Supply- or Demand- Reduction 
(and therefore not maintenance) were coded 0, studies that were Harm-Reduction and not 
maintenance were coded 1, and studies that were Harm-Reduction and maintenance were 
coded 2. 
Chi Square tests do have some limitations, however, in that it cannot discern the 
size, strength, or direction of the relationship between two variables, and can instead only 
determine if the variables are independent of each other or related in some way.  Because 




 While the Chi Square test was used to determine the presence of a relationship 
between the type of approach used and the outcome of the study, and therefore to 
understand the consensus found in the literature regarding effective approaches to heroin 
use and abuse, understanding the reasons for the lack of implementation despite the 
consensus is a bit more complicated.  Overall, this lack of implementation lies in the 
issues plaguing the implementation of policy in response to the heroin epidemic. In the 
case of heroin, the main issue is discrepancies between fields affected by and involved in 
the heroin problem, including but not limited to the criminal justice, medical, legislative, 
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political, and economic fields.  These differences have their roots in group think and goal 
conflict, both of which exacerbate the misalignment between fields, making reaching a 




The first issue from which the misalignment arises is group think. First presented 
as a theory in 1971 by Irving Janis, groupthink is “the mode of thinking that persons 
engage in when concurrence-seeking becomes so dominant in a cohesive ingroup that it 
tends to override realistic appraisal of alternative courses of action” (Janis 1971, 84). One 
of the most common norms in the presence of group think is upholding loyalty to the 
group by maintain the policies to which the group has already committed, even when 
those policies have unintended consequences or are working out badly.  In group 
decision-making settings, members of the ingroup adopt soft-line criticism of their peers, 
leaders, and themselves, and conflict rarely occurs in the decision making process.  This 
is not to say, however, that all groups will succumb to the perils of groupthink in their 
decision making, but rather that any advantages of group decision making are often 
outweighed due to the psychological pressures of cohesion that arise when members of 
the ingroup work closely, share values, and face a crisis situation that stresses the normal 
group decision-making dynamic (Janis 1971). 
 Janis also proposes his main principle of groupthink, which, based on Parkinson’s 
Law, states that, “The more amiability and espirit de corps there is among the members 
of a policy making ingroup, the greater the danger that independent critical thinking will 
 26 
be replaced by groupthink, which is likely to result in irrational and dehumanizing actions 
directed against outgroups” (Janis 1971, 85).   
 Before considering the consequences of groupthink, both as proposed by Janis 
and as evidenced in dealing with the heroin epidemic, it is also important to note how 
groupthink is present in the policy-making process in regards to heroin.  To begin, the 
most typical norm of groupthink is “sticking with the policies to which the group has 
already committed itself, even when those policies are obviously working out badly and 
have unintended consequences…” (Janis 1071, 84).  This is evidenced by not just each 
field involved in the heroin epidemic, but by the larger American attitude toward dealing 
with drugs as well.  When the “War on Drugs” began, it became the All-American cause 
to eradicate drug use with a punitive and legislative approach. The group most involved 
was the bureaucracy, encompassing each and every aspect of policy and every field 
involved- medical, criminal justice, political, and others, though the main source of 
groupthink was law enforcement.  Law enforcement thinks of all the problems it 
addresses, including drugs, as law enforcement problems and, since the federal 
government is typically stronger on law enforcement than health, the main manifestation 
of groupthink was demonstrated in the policy-making process when loyalty to the “War 
on Drugs” overshadowed the facts, when they became apparent, that the punitive policies 
were having negative effects on the criminal justice system, social dynamic, and 
economy. 
 Within each field involved in the policy making process and the heroin epidemic, 
however, groupthink is also apparent.  This is due to the strong bond between members 
of each field; for instance, the bond within groups and associations of medical 
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professionals, lawyers, judges, police, politicians, pharmaceutical companies, social 
workers, and other ingroups of parties involved in and affected by the epidemic mean 
each have a delineated approach toward thinking about and solving the heroin epidemic. 
Most notably groupthink can be seen in the treatment camp, mostly advocated by medical 
professionals. It is the smaller of the two spheres and as it is up-and coming rather than 
previously established, it possesses more of the espirit de corps Janis notes is essential for 




In addition to groupthink, the second issue which exacerbates the misalignment 
between fields is that of goal conflict.  Conflict, in and of itself, is difficult to define, but 
within the organizational setting it has its roots in disagreement, contradiction, and 
incompatibility.  Conflict, itself, should be understood as a dynamic process, 
encompassing a sequence of conflict episodes and relationships where a variety of factors 
characterize the conditions, affect, perception, and behaviors of the parties involved 
(Pondy 1967).  Additionally, conflict affects productivity, stability, and adaptability of an 
organization in the way the organization reacts to the disturbed equilibrium brought about 
by conflict.  For goal conflict specifically, the situation is one where desired outcomes 
appear to be incompatible. In the case of heroin policy, the basic principles of goal 
conflict are maintained and cause serious issues for reaching a policy consensus.  In 
treating the policy making arena as an organization, these principles can be fleshed out in 
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how they directly impact the process of making and implementing policy with which to 
deal with the heroin epidemic. 
Within organizations, there are three models that have been designed to classify 
conflict phenomena.  The one most applicable to conflict in making heroin policy is the 
bargaining model.  This model deals with conflict in competition for scarce resources, 
where there is a discrepancy between the demands of the different parties involved and 
the available resources.  In this case, solving the conflict usually centers around 
increasing the available resources or decreasing the demands of the parties involved.  In 
these interest-group style conflicts, negotiation faces the problem of reaching a consensus 
while maintaining both flexibility in dealing with the other parties and rigidity in one’s 
own demands.  Additionally, this bargaining model is similar to the budgeting process, 
where it is an incremental process building on the previously established conflicts and 
negotiations, but this process faces concealment that attempts to rationalize the decisions 
being made rather than exposing the bargaining process. 
In making policy to deal with the heroin epidemic, goal conflict often falls into 
this bargaining model.  There are scarce resources available for combatting heroin use 
and addiction, and different fields with different goals are vying for those scarce 
resources.  The criminal justice system, historically at least, advocated for spending 
limited resources on punitive measures, while the political realm advocated for spending 
resources on public education campaigns to boost moral and rally societal support around 
anti-drug legislation.  On the other hand, medical fields advocated, and still are, for harm 
reduction programs including needle exchanges on the public health front, public 
education, and funding and access for addicts to maintenance programs.  Historically, the 
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bargaining process was more spread out, with many different fields aiming to achieve 
many different goals, but as of late, this bargaining process has converged on 
maintenance treatments and harm reduction strategies.  This is not to say, however, that 
there is not still bargaining and allocation of scarce resources to be done; although the 
goals are less different now, the fields are still at odds about the best way to manage the 
scarce resources in the most effective and efficient way to achieve their goals. 
In considering this model of conflict, it becomes apparent that while there is 
conflict between the groups, the conflict lies less in the goals and more in the means of 
achieving those goals.  Each field’s goal is to solve the problem of heroin use and abuse.  
That goal, however, takes many different forms: reducing the public harm, reducing the 
harmfulness of engaging in drug use, increasing public awareness and access to 
treatment, and, in the past, increasing punitive measures, reducing the supply of the drug, 
reducing the demand, and increasing anti-drug and drug-control legislation.  Today, 
however, literature in all fields seems to agree on a broad idea that harm reduction 
through maintenance treatment works.  With the unified goal of solving the problem, and 
the consensus that maintenance treatment works, why is conflict still a problem?  L. J. 
Bourgeois III puts it this way: “Agreement on goals without agreement on means 




After exploring both groupthink and goal conflict more in depth, it becomes 
apparent that the general misalignment cited as influencing the policy making process in 
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dealing with the problem of heroin is more specifically “means misalignment”, where the 
fields are unable to agree on the means by which to achieve the goal of implementing 
policy that supports the consensus that maintenance treatment works as an approach to 
the heroin epidemic.  Means misalignment is wherein the problem lies in implementing 
heroin policy.  Because the fields do not agree on the details of the policies, the means by 
which the general idea behind the policy should be realized, a policy consensus cannot be 
reached.  This, of course, is in spite of the mounting evidence and full bodied literature 
discussing the merits of maintenance treatments, which exhibits the goal consensus in 
regard to heroin policy.  Having goal consensus, however, is not sufficient for achieving 
policy consensus, because the details of implementation must be agreed upon as well. 
Bourgeois, cited above, acknowledges that human actors are expected to be 
teleological and goal directed, and that the Western world agrees that the rational way to 
make a decision is to determine a goal, then identify the means to attain that goal.  In his 
study, however, he compares the strategic planning school and the incremental school to 
determine how decision making should proceed.  In the strategic planning school, 
decision makers define goals and objectives, form a list of policy alternatives or means, 
assess the probabilities of consequences for each alternative, make a choice, and then 
take action on those choices.    This school of strategic planning is the traditional and 
normative approach to decision theory, and it is typically accepted that there should be 
agreement on policy makers on the goal priorities of the policy. In the incremental 
school, policy makers look for alternatives until an acceptable solution is found, and the 
goals and means are adjusted while alternatives are evaluated based on analysis of 
incremental differences from the status quo.  Rather than goals being established before 
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evaluating alternatives, the goals and means adjust based on what the current situation 
dictates. 
Overall, this presents a juxtaposition of the two orientations- one of goal 
consensus, where agreeing on the goal will lead to success, and one of means consensus, 
where agreeing on the means and not the goal is the key to success. Bourgeois ultimately 
determines in his comparative study that lack of consensus on means is more troublesome 
to successful policy implementation than disagreement on the ends (goals), and therein 
lies the issue for successful implementation of heroin policy.  Under the assumption that 
the variations in agreement, whether on goals or means, cause differences in 
performance, or successful implementation of policy in this case, Bourgeois study 
supports the idea that the best policy outcomes will arise when the policy making groups 
agree on means and a narrow range of operable goals, and disagree on the less tangible 
goals.  In the case of heroin policy, the means would be the specific policy or policies to 
be implemented.  The narrow range of operable goals would include goals such as 
increasing access to maintenance treatment programs by increasing funding, increasing 
the availability of substitution drugs for addicts, or reducing restrictions on clinicians 
administering the substitution therapies.  The less tangible goals would include ideals 
such as fixing the heroin epidemic, reducing the number of overdose deaths, or 
implementing maintenance treatment policy. 
Similarly, his results support the notions that: 1, consensus on means always 
yields higher performance than disagreement on means; 2, allowing disagreement on less 
tangible goals tends to be associated with better performance; and 3, the worst policy 
outcomes result when goals agreement occurs with means disagreement.  In this way, 
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disagreement on the means may hurt the implementation of policy because the strategies 
of the different groups involved clash, “causing muddled and internally inconsistent or 
incomplete strategies” (Bourgeois 1980, 244).  The situation with heroin policy in 
America is accurately described by the third notion- there is definite goals agreement on 
all the fields and parties involved in the policy-making arena, where they all agree that 
the epidemic would be best resolved through implementation of policy focused on harm-
reduction maintenance treatment, but the disagreement arises when considering the 
means by which to implement that policy directive.  Between the different dosages, time 
frames, environments, administration procedures, costs, and other factors involved in 
maintenance treatment, there is much to be decided upon when it comes to establishing 
the means to reach the goal.  Therefore, it is these policy details, the specific means, that 
hinder implementation of policy.  According to Bourgeois’ typology, reaching a policy 
consensus would benefit from the parties involved agreeing on the means by which to 
achieve the goal of solving the heroin epidemic, and allowing for disagreement on the 
less tangible goals, such as the ideals listed above, would allow for better policy 
outcomes as well. 
Means misalignment is exacerbated by both groupthink and goal conflict.  
Groupthink, as an issue, affects means misalignment in the group’s perspective on the 
means by which the goal should be achieved.  As described, because of groupthink, each 
field is cemented in its own set of means geared toward the fields tangible subset of goals 
that fall within the widely agreed-upon goal to implement policy that supports 
maintenance treatment to deal with the heroin epidemic.  Groupthink is what keeps the 
fields from negotiating on the details of implementing policy, the means.  Each field has 
 33 
a subset of goals and its own “best” way of achieving these goals within the larger 
framework of the consensus exhibited by the literature.  Because the fields are 
approaching the issue as an ingroup under the influence of groupthink, they do not 
approach policy making unencumbered by their on preconceived perspectives. Rather, 
they approach them with reduced realistic evaluation of the alternative sets of means 
being presented and are often irrational in their avoidance of information that contradicts 
their set point of view, which makes negotiation between the fields nearly impossible. 
Goal conflict, the second issue exacerbating means misalignment, has a more 
straightforward relationship with means misalignment. It is not focused on the broad goal 
that the fields agree on- that of implementing maintenance treatment policy. The goal 
conflict in this situation is instead on what Bourgeois describes as the tangible goals, the 
subset of more specific and concrete goals that each field diverges on.  Because of this 
divergence on exactly what the goal is under the umbrella of solving the problem of drug 
use and abuse, the fields have different means for achieving those goals, and without 
agreement on the means, a policy consensus will not be reached. 
In answering the question of why, in the face of mounting evidence in favor of 
maintenance treatment approaches to heroin, there is a lack of policy consensus and 
implementation, exploring the root issues of groupthink and goal conflict, as well as the 
ultimate means misalignment between fields, goes far to address the lacking 
implementation of policy in response to the heroin epidemic.  It is not the broad goal of 
eradicating the problem of heroin use and abuse that limits policy consensus.  Instead, it 
is the misalignment on the means by which the policy goal should be achieved, the details 
of the policy’s execution, that hinders implementation.  With groupthink limiting the 
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capacity of the fields to attempt negotiations due to the fields being unwilling to 
relinquish commitment to their unique point of view and goal conflict between the fields’ 
specific subsets of goals influencing the different means by which the fields favor 
achieving those goals, means misalignment is at the heart of lacking policy consensus and 




As with any study, a variety of methodological concerns and issues of data 
collection and analysis were found throughout the project.  Many of these concerns have 
their roots in the issues cited above, and while some were addressed as best as possible 
given the circumstances of the study and available resources, some concerns were had 
due to the nature of this specific study and merit heeding.  Along with issues associated 
with the type of study being a meta-analysis, this specific study had four main issues that 
were more specific to the circumstances of this particular project: lacking variation in 
data, drop out rates, selection bias, and concerns of special populations and ethics. 
 The first set of issues and limitations arises simply from the nature of the meta-
analysis.  Although meta-analyses are used in many disciplines to incorporate findings 
from many studies, the meta-analysis itself remains controversial due to the use of 
dissimilar studies, publication bias, and inclusion of poor quality studies.  In many meta-
analyses, the researchers define the subject so broadly that studies are often compiled into 
a data set with disregard for important differences between the studies that would warrant 
them incomparable.  In this meta-analysis, it is clear that the subject is defined very 
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broadly, but this broadness plays into the broad scope of the research question itself- 
what is the consensus of literature on combatting the heroin epidemic?  Without a team of 
researchers to peruse abstracts or abstract-scanning software, however, it is quite possible 
that some very distinct studies were included in the data set, especially because the 
inclusion criteria were not overly restrictive.  Presumably, the studies themselves are 
similar enough to determine an outcome for coding that would not discredit the merit of 
this meta-analysis. 
 Publication bias, which will also be discussed within the issues associated with 
this specific meta-analysis, arises due to the fact there exists a bias toward publishing 
studies with statistically significant results, leaving many studies with insignificant or 
negative results unpublished. While a non-result or weak result are still results, they are 
not the kind that get published.  This likely leads to a biased sample of studies and 
overestimation of the effects of what is being studied.  Once again, lacking resources 
meant I was unable to identify or include unpublished studies, which limits how far this 
project could go in mitigating the effects of publication bias, but, based on the 
circumstances of data collection and goals of this project, the methods suffice. 
 A final limitation of general use of a meta-analysis is that of including poor 
quality studies.  While the inclusion criteria for this project did not include any formal 
methodological quality controls, soft screening practices for each study were utilized to 
ensure that the studies included in this analysis possessed a basic level of methodological 
merit.  It is quite possible that studies that were not methodologically sound were 
included in this analysis, but no study is completely free from weaknesses in 
methodology and judging the strength of each study would have been cumbersome and 
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may have introduced bias from the criteria assessing quality.  It is assumed, however, that 
the studies included in this analysis were reviewed by their respective publishers with 
care enough that any study prompting serious concern would not have been published in 
the first place, and therefore would have been excluded preveniently. 
 The second set of issues are related more to the specifics of this project than 
general limitations of conducting a meta-analysis.  First, the data set was lacking in 
variation.  96% of the studies included in the data set were harm reduction, and 87.5% of 
those harm reduction studies were classified as maintenance studies.  Clearly, the 
majority of the studies included were harm reduction maintenance studies and, further, 
86.9% of these studies were classified as having worked.  This bias in the literature could 
be due to a few things.  For one, groupthink, as explored earlier, discourages novel 
information from being presented and discussed within fields.  Because of this, if the 
group assumes the majority convention that harm reduction, maintenance treatments 
work, that is the literature that will be accepted, discussed, and presented as fact, simply 
because the group does not acknowledge conflicting information.  Additionally, 
publication bias comes into play here just as it does with general meta-analyses.  I used 
the available literature to compile my data set, and the available literature is what was 
able to get published. In academia, those studies that do not work do not get published.  
This introduces a bias towards studies working, which means that when publication bias 
is combined with groupthink bias, this meta analysis was swayed toward overestimating 
the success of the approach favored under groupthink. 
 The second issue unique to this study is that of high drop out rates.  When 
investigating the literature and, more specifically, the studies included in this dataset, a 
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recurring methodological concern was drop out rates.  Many of the studies were of a 
small-n to begin with, so having even only a few subjects drop out of the study meant the 
validity of the study could be called into question, simply because the sample may have 
lost representativeness.  When considering the subject matter of this project and the 
studies on which it is based, it becomes a question of if the approach deemed to be “most 
successful”, in this case maintenance treatments, is only successful because those for 
whom it is not successful drop out of the study, leaving only subjects for whom the 
approach achieved the goal in the end. This could easily inflate the successful outcome of 
studies.  Moreover, when it comes to drug use and approaches, if the approach is not 
working (whether this sense of success is felt by the subject/patient or the researcher) the 
subject will either drop out by their own choice because continuing with an ineffective 
approach is irrational or drop out due to mortality, the drug use or comorbidity taking 
their life.  Therefore, those for whom the approach did not work were not present at the 
conclusion of the study for their negative results to be included. If only successful 
participants remain at the end, the results will be skewed toward success. 
 Third, selection bias was an additional limitation of this project.  Without abstract 
screening software or even a second set of eyes to review or challenge my own coding, it 
is quite possible that some of the studies included should not have been or, when coded, 
were coded incorrectly.  When dealing with such an abstract subject, however, there is 
bound to be some discretionary error.  The preconceived notions with which I was 
evaluating these studies are different than those of other researchers, and are additionally 
different than the biases applied by a computer program.  Because of this, selection bias 
and natural human error are concerns to be had in evaluating the methods of this study. 
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 The fourth and final limitation of this project is that of dealing with ethics and 
concerns in dealing with special populations.  The nature of heroin use is that it is not 
only illegal, but also socially condemned and a sensitive topic of discussion. Within the 
history of heroin, treatment approaches were often experimented with in a prison setting, 
and while there are now guiding ethical standards that deem much of that 
experimentation taboo, utilizing special populations of prisoners or corrections 
populations in drug use studies is not uncommon.  This is mostly due to the fact that it is 
difficult to find heroin users who are willing to step forward, admit their illicit behaviors, 
and submit themselves to research. Utilizing corrections populations means that they 
have already been convicted, their drug use being known, and that incentives can be 
offered to encourage participation.  
This, of course, lends itself to ethical concerns of coercion, but also to concerns of 
selection bias, sampling bias, and skewing of results.  With ulterior motives for 
participation coupled with motives for showing the approach to be successful, the results 
of studies using corrections populations lack validity.  There is also a question of the 
representativeness of the sample being used because there may be other variables linking 
the type of prisoner that self selects into participating or motivations of prisoners to 
success in different approaches.  Related to this idea is motivation, on which few studies 
report data.  Motivation for not only participating but also being successful in the 
treatment goals may be important in explaining the differences between subjects and their 
success.  While studies must go through Institutional Review Boards and are reviewed 
before publication for being methodologically sound, it is still possible that motivation 
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and sampling were prodigious issues in the studies utilized in this project’s data set, and 
therefore influenced this project as well. 
Keeping in mind these issues and limitations of not only general meta-analyses, 
but also of this specific project, it is notable that no study is perfect in its methods.  Meta-
analyses themselves, however, are a secondary analysis technique, and are therefore 
subject to the weaknesses of the studies which they employ.  The generalizability of 
meta-analyses is limited to the state and scope of the literature on which it is founded.  In 
this case, the research question examined the consensus of the literature on approaches to 
the heroin epidemic, so using the available literature and relying on its characteristics is 
acceptable, but any results or conclusions of this analysis should still be understood 




 This project is a meta-analysis of 100 quantitative studies regarding approaches to 
heroin addiction and abuse with the goal of addressing the question, “What is the 
consensus of the literature in regard to heroin policy?”  Besides the standard descriptive 
statistics, cross tabulation tables were used to explore any patterns in the literature and 
Pearson’s Chi Square and Craver’s V statistics were also used to quantify the relationship 
between variables. 
 To begin, summary statistics were used to get a feel for the distribution of the 
data, which can be seen in Table 1.  Each observation was evaluated on three 
dichotomous variables: as a harm reduction approach, as a maintenance approach, and if 
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it worked, where positive answers to these variables were given a 1 and negative answers 
were given a 0.  Additionally, a breaking variable was created using the data from the 
first two variables that coded each observation on a scale of 0 to 2 based on the amount of 
maintenance involvement.  Those that received zeroes across the board were coded zero 
on this breaking variable as not harm reduction and therefore not maintenance. Those 
receiving a one were harm reduction, but not maintenance and those receiving a two were 
harm reduction and maintenance.   
Table 1: Summary Statistics of Each Variable 
Variable n = Mean Standard Deviation Min Max 
Harm Reduction 100 .96 .197 0 1 
Maintenance 100 .84 .368 0 1 
Worked 100 .8 .402 0 1 
Treatment (0-2) 100 1.8 .492 0 2 
 
Although the statistics indicate that the data was skewed toward maintenance approaches, 
this does not necessarily denote a problem with the data or its collection. Rather, it 
indicates that there is a gap in the literature surrounding supply reduction approaches. 
 
The cross-tabulation table, Table 2, explains much of the story to be told by the 
literature by allowing for the examination of if there is a relationship between variables, 
or if one is dependent on (or if not, independent of) the other.  It displays the observed 
and expected frequencies of each type of case, comparing if the variable worked (or did 
not work) with the type of approach used (on the ordinal breaking variable) where the 
first row shows studies whose approach of interest did not work, and the second shows 
those that did.  The rows indicated by “expected” contain the number of cases that should 
fall into that category based on the sample if there were no relationship between the type 
of approach and if it worked.  The rows indicated by “observed” contain the number of 
cases from the sample that actually fell into the category. 
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For supply reduction, more did not work and less did work than would be 
expected if there was no relationship between the approach and its success.  For harm 
reduction approaches that were not maintenance approaches, more did not work and less 
did work than could be expected, similar to the supply reduction category.  For harm 
reduction approaches that were maintenance, less did not work and more did work than 
could be expected if there existed no relationship between the approach and its success.  
Overall, the evidence in these compared frequencies displays a relationship between the 
type of approach and the outcome of the study. 









































Total 4 12 84 100 
X2 = 22.0238, p = < .001 
Cramer’s V = .4693, p = <.001 
 
This table displays a potential relationship between these two variables that is confirmed 
by both the Chi Square and Cramer’s V statistic. 
 
 While the cross tabulation table alone indicates a potential relationship between 
the two variables, where the approach used in the study is related to the outcome of the 
study, statistical tests can provide an opportunity for inferences to be made about the 
population.  Running a Pearson’s Chi Square Test for Independence yielded a X2 statistic 
of 22.0238 (p-value < .001).  While this number does not indicate strength or direction of 
the relationship, nor that one variable causes the variation in the other, it does allow for 
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the conclusion that there is a significant relationship between the two variables in the 
literature. 
 A Cramer’s V Measure of Association was also run to determine the strength of 
the relationship between approach and outcome, yielding a result of .4693 (p-value < 
.001).  This indicates a moderately strong, and nearly very strong, relationship between 
what approach is used and the outcome of the approach, where the more maintenance-
focused an approach is, the more likely it is to work. 
 Upon evaluation of the cross tabulation table and the Chi Squared and Cramer’s V 
statistics, it can be concluded that there is a relationship between the approach used and 
the outcome of using that approach, where maintenance approaches are more likely to 
work than harm reduction strategies that are not maintenance and, subsequently, supply 
reduction strategies.  Based on this assessment, where the units of analysis are pieces of 
literature regarding approaches to heroin addiction and abuse, the consensus of literature 





 Statistical analysis on its own only tells part of the story. What are the 
implications of the results?  The analysis confirmed that there is a relationship between 
the approach used and the outcome of using that approach, where the more maintenance-
focused approaches are shown to be the most effective compared to other harm-reduction 
and supply- and demand- reduction strategies.  In this way, the literature has an 
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established consensus that maintenance treatments work in addressing the problem of 
heroin, but understanding and applying that consensus must be considered in light of 
caveats discussed regarding data collection.  
The first concern is of the lack variation in the data. There is a gap in the 
literature, as evidenced by the lack of criminal justice studies focusing on supply and 
demand reduction strategies, that may be brought on by groupthink, where information 
that contradicts the ingroup’s accepted thought pattern is neither presented nor discussed.  
Similarly, the lack of criminal justice research on the topic could be due to ethical 
concerns in dealing with the special population of prisoners.  That subgroup of the 
population is not easy to study due to issues of coercion and bias, and studies that are 
geared toward studying prison populations are not generalizable to the public, which 
limits the conclusions that can be drawn based on criminal justice research of this type 
and further makes publication of such studies difficult. 
 The second concern is the issue of high drop out rates.  The recurring 
methodological concern of dropout rates in the studies used in this analysis indicates that 
saying “maintenance works” may not divulge the entire picture.  Rather, a more accurate 
interpretation of the results of the analysis in light of the dropout rates is that maintenance 
treatments act as a screening mechanism.  Because those for whom maintenance 
treatments do not work typically drop out of the study or are excluded in other ways 
(death, for example), the subjects left at the end of the study are those for whom the 
treatment worked, inflating the success of the approach. In this way, it becomes apparent 
that maintenance approaches, arguably more involved than other approaches, require a 
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certain motivation for success that the other strategies do not, meaning that maintenance 
treatments work for those who want them to work.   
Even with these concerns in mind, the consensus of the literature was confirmed, 
and the question still remains as to why policy is not being implemented in line with what 
the literature supports.  In looking back at the history of heroin, part of this lack of policy 
may lie in the methods used over time in dealing with addiction.  The effects of the 
methods used can be seen in the dichotomy between the European, specifically British, 
approach and the American approach.  On the one hand, England has approached 
addiction through treatment, with a uniquely medical perspective, focusing on Harm 
Reduction on the treatment side with emphasis on the addicted individual.  On the other 
hand, the United States approached addiction with an emphasis on punitive and 
prohibitive methods, allowing the criminal justice system and crime-control perspectives 
to lead the charge with a focus on supply and demand reduction through legislative 
action.  This focus meant the complex legislative process hindered implementation of 
effective policy because, rather than a unified goal of treatment, the country was tasked 
with integrating the goals of the many fields involved into a cohesive policy, which has 
been proven to be nearly impossible. 
That is where this analysis comes in; the consensus has been reached in the 
literature that maintenance works, but it is the details of implementing the maintenance 
treatment programs that cause the disagreement.  Policy implementation has been 
hindered by both goal conflict and group think, both of which exacerbate the means 
misalignment between fields and make reaching a consensus on the appropriate policy 
difficult.  All the parties involved recognize that there is an issue that can be resolved by 
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maintenance treatments, and this is demonstrated by the analysis in this project. 
However, the fields do not agree on the details of the policy, the best way to achieve 
success with maintenance treatments.  It is not the goal of eliminating heroin use and 
abuse that limits policy, rather it is the misalignment on the means by which the policy 
goal should be achieved, the details, that hinder implementation. History is history, 
however, and America has faced, and will continue to face, many difficulties in 
implementing policy to deal with the heroin epidemic successfully, but that is not to say 
that a solution is impossible. 
 In light of the issues of this study and thoughts regarding why policy is not being 
implemented despite the consensus of the literature, the story told by the analysis in this 
project is made more complete.  By considering the gap in criminal justice literature and 
the effects of dropout rates, the conclusion drawn from the analysis is that maintenance 
works for those who want it to work. Coupled with the idea that it is the details of 
implementation that delay policy, rather than the broad consensus that maintenance 
approaches are effective in dealing with heroin use and abuse, the United States needs to 
address the issue of consensus by not getting caught up in the details and language of the 
issue and, instead, focus on broad legislation where the details of implementation can be 
worked out based on each community’s unique situation, the demand for services, and in 
seeking to use resources in the most effective and efficient manner.   
 Moving forward, further research should be done to investigate the characteristics 
of those individuals for whom maintenance treatments are successful, to determine for 
what sub-population of addicts maintenance treatments work the best, and to investigate 
if motivation plays a role in the success of both maintenance approaches and other 
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approaches to addressing addiction.  Additionally, country comparisons to discern 
additional ways in which the government systems affect the formulation and 
implementation of drug policy and examining the successes of different approaches 
internationally could impact the way the United States approaches drug policy 




This project aimed to aid legislators by presenting quantitative evidence on what 
policies existing literature supports as working in dealing with the problem of heroin use 
in order to shift policies to a more effective approach.  In doing so, it sought to address 
the question of why, in the face of a seemingly present consensus within the literature, 
policy is not being implemented.  Upon review and coding of 100 quantitative outcome 
evaluations of heroin abuse treatment programs or specific techniques, the Chi Square 
analysis, associated cross tabulation table, and Cramer’s V Measure of Association 
indicated that there is a relationship between the approach used and the outcome of the 
approach, where maintenance approaches are more likely to work than harm reduction 
strategies and, subsequently, supply reduction strategies.  
While there were limitations in the data collection methods used and caveats 
including lacking variation in the data and high drop out rates, the results can be 
interpreted to show a consensus in literature that maintenance approaches work in 
addressing the problem of heroin.  With this consensus, it is expected that policy would 
be implemented following the literature, but that is not the case. Examining the methods 
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used over time in dealing with addiction, along with the presence of goal conflict and 
groupthink exacerbating the means misalignment between fields, offers a probable 
explanation for the difficulties legislators face in reaching a policy consensus, and 
therefore in implementing effective policy.  The study concluded that, while the literature 
finds consensus on the idea that “maintenance works”, the details of implementation 
cause disagreement between fields; overall, maintenance approaches work for those who 
want it to work, and policy makers should focus on implementing broad legislation where 
the details of implementation can be worked out based on each community’s unique 
situation, the demand for services, and in seeking to use resources in the most effective 
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